Navigation Links
Takeda to Acquire Nycomed
Date:5/18/2011

The group employs approximately 50,100 people. The registered shares (CSGN) of Credit Suisse's parent company, Credit Suisse Group AG, are listed in Switzerland and, in the form of American Depositary Shares (CS), in New York. Further information about Credit Suisse can be found at www.credit-suisse.com.

About Avista Capital PartnersAvista Capital Partners is a leading private equity firm managing approximately $4 billion of committed capital with offices in New York, Houston, and London. Founded in 2005, Avista's strategy is to make controlling or influential minority investments in growth-oriented energy, healthcare, media, industrial and consumer businesses. Through its team of seasoned investment professionals and industry experts, Avista seeks to partner with exceptional management teams to invest in and add value to well-positioned businesses. For more information visit: www.avistacap.com.

About Coller International Partners CapitalColler Capital - the global leader in Private Equity Secondaries - has invested in Nycomed through its funds Coller International Partners IV and V.

AdvisorsDeutsche Bank is acting as financial advisor to Takeda in this acquisition.
Goldman Sachs and Credit Suisse acted as financial advisors to Nycomed.

Takeda's Forward-looking statementsThis press release contains forward-looking statements regarding Takeda's plans, outlook, strategies, and results for the future. All forward-looking statements are based on judgments derived from the information available to Takeda at this time. Forward looking statements can sometimes be identified by the use of forward-looking words such as "may," "believe," "will," "expect," "project," "estimate," "should," "anticipate," "plan," "continue," "seek," "pro forma," "potential," "target, " "forecast," or "intend" or o
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S.
2. Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
3. Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
4. Takedas Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed
5. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
6. Takeda Initiates Two Phase III Studies with Vedolizumab (MLN0002) in Patients with Inflammatory Bowel Disease
7. Takeda to Revise Timing of Alogliptin and Alogliptin/ACTOS MAA Filings in Europe
8. Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes
9. Takeda Provides Update on the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl)
10. Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin, An Investigational Treatment for Type 2 Diabetes
11. Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... and BRIDGEWATER, N.J. , ... REGN) and Sanofi US (EURONEXT: SAN and NYSE: SNY) ... organizations to launch Cholesterol Counts , an awareness ... cholesterol, their numbers, and the risks associated with high ... www. CholesterolCounts .com to take a brief ...
(Date:12/15/2014)... , Dec. 15, 2014   DaVita ... one of the nation,s largest and most innovative ... its business units, DaVita Clinical Research  (DCR) and  ... to further expand its extensive clinical research and ... kidney disease (CKD) and end-stage renal disease (ESRD), ...
(Date:12/13/2014)... , December 12, 2014 ... announced the addition of the  "Global Catheters ... Share, Global Trends, Company Profiles, Analysis, Segmentation ... to their offering.       (Logo: ... made up of medical grade material such ...
Breaking Medicine Technology:Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 2Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 3Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 5Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 6DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 3DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 4Global Catheters Market (Product Types and Geography) - Forecast to 2020 2Global Catheters Market (Product Types and Geography) - Forecast to 2020 3
... 2, 2011 Aoxing Pharmaceutical (NYSE Amex: ... company focusing on research, development, manufacturing and distribution ... operating subsidiary in China, Hebei Aoxing Pharmaceutical Group ... State Intellectual Property Office of The People,s Republic ...
... TARRYTOWN, N.Y., May 2, 2011 Regeneron Pharmaceuticals, Inc. (Nasdaq: ... of America Merrill Lynch 2011 Health Care Conference on Tuesday, ... Eastern Time).  The session may be accessed through the Company,s ...  An archived version of the presentation will be available after ...
Cached Medicine Technology:Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film 2Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film 3
(Date:12/17/2014)... Mass. (PRWEB) December 17, 2014 ... of Osteopathic Medicine (ACOM), which welcomed its inaugural ... Desktop Infrastructure (VDI) to seamlessly support bring your ... – and teaching – experience. The solution, comprised ... NetScaler , Dell server and storage infrastructure ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 In its ... and its Argus Claim Review division have recently ... the most common ways savings are achieved on behalf ... attributes millions of dollars in savings to Argus each ... 2013. , As explained by Tom Doney, Cypress president ...
(Date:12/17/2014)... -- As gas prices rose in recent years, so ... In times of gas increases, more people start ... the researchers explained. They examined data gathered between ... number of motorcycle registrations in the United States and ... analysis revealed a strong association between rising gas prices ...
(Date:12/17/2014)... Dec. 16, 2014 (HealthDay News) -- Greater participation in ... study finds. Researchers followed kids in the nonprofit ... poor children in Los Angeles. Over two years, ... improvements in how the brain processes speech and reading, ... Also, the benefits of active participation in music classes ...
(Date:12/15/2014)... A recent survey found that the most ... skin health and beauty were: “Connections,” “climate,” “career” and ... and health advocate and radio host Sharon Kleyne agrees ... survey and the Four C’s.* Kleyne notes, however, that ... would benefit from paying attention to one’s daily fresh ...
Breaking Medicine News(10 mins):Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 2Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 3Health News:Out-of-Network & Medical Necessity Reviews among Top Ways TPA Identifies Significant Medical Claim Savings 2Health News:When Gas Prices Go Up, So Do Motorcycle Accidents, Study Finds 2Health News:Music Classes Boost Language Skills, Study Says 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 3
... Cutaneous leishmaniasis (CL) is a non-lethal disease but can ... be prevented with a rapid and accurate diagnosis and ... it is essential to establish the number of parasites ... before, during and after treatment in order to assess ...
... the life sciences, protocols provide individual sets ... experiments in their own laboratory. These documents ... of experiments that include the safety bias, ... standards for the experiment. , ...
... ... Partnership, PALO ALTO, ... VAR ) and BrainLAB AG are today announcing,that they have ... the most successful technologies,from both companies to offer superior noninvasive treatment ...
... 24 Sports,and nutritional product manufacturer, Natural Nutrition ... today that it will,launch in February 2008, its ... with a FUSION of rich and 100% REAL ... all natural nutrition bars are loaded with a,combination ...
... creates national integrated healthcare real estate company providing ... of services to hospitals and physicians ... of $55 Million, CHARLOTTE, N.C., Jan. 23 Cogdell ... a definitive merger agreement,to acquire 100 percent of the stock ...
... and its,participating vendors raised $137,500 during its 2007 ... awareness at the Barbara Ann Karmanos,Cancer Institute., ... of our vendors and purchases by our loyal,customers, ... to such an,important cause," said Rick Going, president ...
Cached Medicine News:Health News:Improved diagnosis of cutaneous leishmaniasis thanks to new techniques 2Health News:Springer launches Springer Protocols 2Health News:Varian and BrainLAB Announce Rapid Uptake of Powerful and Versatile Radiosurgery Platform 2Health News:Varian and BrainLAB Announce Rapid Uptake of Powerful and Versatile Radiosurgery Platform 3Health News:Natural Nutrition Launches All Natural FUSION Fruit Bar Line 2Health News:Cogdell Spencer Inc. Announces Merger with Marshall Erdman and Associates 2Health News:Cogdell Spencer Inc. Announces Merger with Marshall Erdman and Associates 3Health News:Cogdell Spencer Inc. Announces Merger with Marshall Erdman and Associates 4Health News:Cogdell Spencer Inc. Announces Merger with Marshall Erdman and Associates 5Health News:Kroger Pink Tag Campaign Raises $137,500 for Breast Cancer Research and Awareness at Karmanos Cancer Institute 2Health News:Kroger Pink Tag Campaign Raises $137,500 for Breast Cancer Research and Awareness at Karmanos Cancer Institute 3
... of a heartbeat. The bodys warmth beneath ... These vital signs are yours to guard, ... of Temperature Monitoring products helps you do ... to provide the most comfortable and precise ...
... The bodys warmth beneath drapes. The life-giving ... are yours to guard, measure, stabilize and ... products helps you do your job, giving ... most comfortable and precise management of your ...
... stabilization of the capsular bag in complicated ... Tension Ring has application in several different ... available for patients with pseudoexfoliation syndrome. Many ... tension ring, especially those in whom you ...
... The Smartlipo laser provokes the breaking ... adipose cells, transforming them into an ... eliminated in a natural manner. ... harmonious body shape in a short ...
Medicine Products: